Pancreatic Cancer Research

ResearcherRutgers, The State University of New JerseyNo recent work listed

Elizabeth A. Poplin

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5050307933. Sources: ClinicalTrials.gov.

Their work

Papers
4 (first author 0, last author 1)
Trials
3 (principal investigator on 2)
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2003: 1 trial · 2004: none · 2005: 1 trial · 2006: none · 2007: none · 2008: none · 2009: none · 2010: 1 trial · 2011: none · 2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper

Papers 4

  1. Response Rate Following Albumin-Bound Paclitaxel Plus Gemcitabine Plus Cisplatin Treatment Among Patients With Advanced Pancreatic Cancer: A Phase 1b/2 Pilot C… Co-author DOI 10.1001/jamaoncol.2019.3394↗
  2. Adjuvant therapeutic strategies for resectable pancreatic adenocarcinoma. Co-author DOI 10.21037/apc.2018.07.05↗
  3. Randomized, multicenter, phase II study of CO-101 versus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma: including a prospective eval… Co-author DOI 10.1200/jco.2013.51.0826↗
  4. A Multi-institutional Phase 2 Study of Imatinib Mesylate and Gemcitabine for First-Line Treatment of Advanced Pancreatic Cancer. Last author PMID 22888387↗

Trials 3

  1. Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery Principal investigator NCT00669734↗
  2. Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer Principal investigator NCT00161213↗
  3. Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Study chair NCT00058149↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. John J. Crowley · 1 shared paper, 2020 · strength 0.09
  2. Gayle Jameson · 1 shared paper, 2020 · strength 0.09
  3. Ramesh K. Ramanathan · 1 shared paper, 2020 · strength 0.09
  4. Hani M. Babiker · 1 shared paper, 2020 · strength 0.09
  5. Erkut Hasan Borazanci · 1 shared paper, 2020 · strength 0.09
  6. Daniel D. Von Hoff · 1 shared paper, 2020 · strength 0.09
  7. Michael T. Barrett · 1 shared paper, 2020 · strength 0.09
  8. Nikhil Yegya‐Raman · 1 shared paper, 2018 · strength 0.08
  9. Salma K. Jabbour · 1 shared paper, 2018 · strength 0.08
  10. Mihir Maheshkumar Shah · 1 shared paper, 2018 · strength 0.08
  11. Darren R. Carpizo · 1 shared paper, 2018 · strength 0.08
  12. Rebecca Anne Moss · 1 shared paper, 2012 · strength 0.03
  13. Mary F. Mulcahy · 1 shared paper, 2012 · strength 0.03
  14. Andrew R. Allen · 1 shared paper, 2013 · strength 0.03
  15. Steffen Ormanns · 1 shared paper, 2013 · strength 0.03
  16. Adam Paul Dicker · 1 shared paper, 2013 · strength 0.03
  17. Volker Heinemann · 1 shared paper, 2013 · strength 0.03
  18. Claudio Bassi · 1 shared paper, 2013 · strength 0.03
  19. Roland E. Andersson · 1 shared paper, 2013 · strength 0.03
  20. Harpreet Singh Wasan · 1 shared paper, 2013 · strength 0.03
  21. Stefan Hubert Boeck · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.